Clover Biopharmaceuticals’ COVID-19 Vaccine 67% Effective In Large Trial

Reuters (9/22, Liu, Woo) reports, “A potential COVID-19 vaccine from China’s Clover Biopharmaceuticals was 67% effective against COVID-19 of any degree of severity and 79% against the highly infectious Delta variant in a large trial, the company said on W...